LONDON, May 22, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics (AUTL) plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results